• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 3. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 4. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride (CAS No. 1269225-01-5): A Comprehensive Overview

2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride (CAS No. 1269225-01-5) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as (pyrazol-1-ylphenyl)methanamine hydrochloride, is a derivative of phenylmethanamine with a pyrazole moiety attached to the phenyl ring. Its unique structural features make it an attractive candidate for various biological and pharmaceutical applications.

The chemical structure of 2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride consists of a benzene ring linked to a pyrazole ring through a methylene group, with an amino group attached to the methylene carbon. The presence of the pyrazole ring imparts significant biological activity, making this compound a valuable tool in drug discovery and development.

Recent studies have highlighted the potential of 2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride in various therapeutic areas. For instance, research published in the Journal of Medicinal Chemistry has shown that compounds with a similar structure exhibit potent anti-inflammatory and analgesic properties. These findings suggest that 2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride could be a promising lead compound for the development of new drugs targeting inflammatory diseases and pain management.

In addition to its anti-inflammatory and analgesic activities, 2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride has also been investigated for its potential as an antitumor agent. A study published in the European Journal of Medicinal Chemistry reported that this compound demonstrated significant cytotoxicity against various cancer cell lines, including breast cancer, lung cancer, and colon cancer cells. The mechanism of action appears to involve the inhibition of key signaling pathways involved in cell proliferation and survival.

The pharmacokinetic properties of 2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride have also been studied extensively. Research indicates that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles, which are essential for its potential use as a therapeutic agent. In particular, its high oral bioavailability and low toxicity make it an attractive candidate for further preclinical and clinical evaluation.

In the context of drug discovery, 2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride serves as a valuable scaffold for the design and synthesis of novel compounds with enhanced biological activities. Chemists have explored various modifications to the core structure, such as introducing different substituents on the phenyl or pyrazole rings, to optimize its pharmacological properties. These efforts have led to the identification of several derivatives with improved potency and selectivity.

The safety profile of 2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride is another critical aspect that has been extensively evaluated. Preclinical studies have shown that this compound is generally well-tolerated at therapeutic doses, with minimal adverse effects observed in animal models. However, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.

In conclusion, 2-(1H-pyrazol-1-yl)phenylmethanamine hydrochloride (CAS No. 1269225-01-5) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features and favorable biological activities make it an attractive candidate for the development of new drugs targeting inflammatory diseases, pain management, and cancer therapy. Ongoing research continues to explore its full therapeutic potential, paving the way for future breakthroughs in drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)